On Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug Administration (FDA), the regulatory body in the United States. These observations pertain to its biologics manufacturing facility located in Bachupally, Hyderabad.
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
Reviewed by karthi
on
October 12, 2023
Rating:
No comments: